Personal Genomics and the Future of Healthcare
Dale Yuzuki (Next Generation Technologist)
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List
Luke Timmerman (Xconomy)
EMA: Opportunity Costs of Risk-Averse Approaches Must be Taken into Account by Regulators
Alexander Gaffney (Regulatory Focus - RAPS)
"The Emperor of All Maladies": Why Our Society Overfunds Internet Companies and Underfunds Cancer Research
Glenn Kelman (CEO of Redfin)
The Value-Destroying Curse of a Poor Capital Structure
David Sable (and other secrets of the buy side)
Twenty tips for interpreting scientific claims
William J. Sutherland, David Spiegelhalter, Mark Burgman (Nature)
Looking for a holiday gift idea for family, friends, colleagues or yourself? BiotechDueDiligence has curated a collection of over 30 books of interest to the biotech enthusiast - check out the complete list.
Dale Yuzuki (Next Generation Technologist)
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List
Luke Timmerman (Xconomy)
EMA: Opportunity Costs of Risk-Averse Approaches Must be Taken into Account by Regulators
Alexander Gaffney (Regulatory Focus - RAPS)
"The Emperor of All Maladies": Why Our Society Overfunds Internet Companies and Underfunds Cancer Research
Glenn Kelman (CEO of Redfin)
The Value-Destroying Curse of a Poor Capital Structure
David Sable (and other secrets of the buy side)
Twenty tips for interpreting scientific claims
William J. Sutherland, David Spiegelhalter, Mark Burgman (Nature)
Looking for a holiday gift idea for family, friends, colleagues or yourself? BiotechDueDiligence has curated a collection of over 30 books of interest to the biotech enthusiast - check out the complete list.
RSS Feed
